Formulation, Preparation and Evaluation of Nanostructured Lipid Carrier Containing Naringin and Coix Seed Oil for Anti-Tumor Application Based on “Unification of Medicines and Excipients”

References

• JemalA, BrayF, MMC, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi:10.3322/caac.2010721296855
   PubMed Web of Science ®Google Scholar
• DikaIE, Abou-AlfaGK. Treatment options after sorafenib failure in patients with hepatocellular carcinoma. Clin Mol Hepatol. 2017;23(4):273–279. doi:10.3350/cmh.2017.010829151326
   PubMed Web of Science ®Google Scholar
• KudoM, FinnRS, QinS, et al. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised Phase 3 non-inferiority trial. Lancet. 2018;391:1163–1173. doi:10.1016/S0140-6736(18)30207-129433850
   PubMed Web of Science ®Google Scholar
• HeimbachJK, KulikLM, Richard FinnMD, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67:358–380. doi:10.1002/hep.2908628130846
   PubMed Web of Science ®Google Scholar
• WangD, YangC, WangZ, et al. Norcantharidin combined with coix seed oil synergistically induces apoptosis and inhibits hepatocellular carcinoma growth by downregulating regulatory T cells accumulation. Sci Rep. 2017;7(1):9373. doi:10.1038/s41598-017-09668-228839202
   PubMed Web of Science ®Google Scholar
• MaP, MumperRJ. Paclitaxel nano-delivery systems: a comprehensive review. J Nanomed Nanotechnol. 2013;4(2):1000164. doi:10.4172/2157-7439.100016424163786
   PubMedGoogle Scholar
• AiT, ShangW, YanH, et al. Near infrared-emitting persistent luminescent nanoparticles for hepatocellular carcinoma imaging and luminescence-guided surgery. Biomaterials. 2018;167:216–225. doi:10.1016/j.biomaterials.2018.01.03129573651
   PubMed Web of Science ®Google Scholar
• BentzKC, SavinDA. Hollow polymer nanocapsules: synthesis, properties, and applications. Polym Chem. 2018;9:2059–2081. doi:10.1039/C8PY00142A
   Web of Science ®Google Scholar
• KovacevicA, SavicS, VuletaG, et al. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure. Int J Pharm. 2011;406(1):163–172. doi:10.1016/j.ijpharm.2010.12.03621219990
   PubMed Web of Science ®Google Scholar
• WeberS, ZimmerA, PardeikeJ. Solid lipid nanoparticles (SLN) and Nanostructured lipid carriers (NLC) for pulmonary application: a review of the state of the art. Eur J Pharm Biopharm. 2014;86:7–22. doi:10.1016/j.ejpb.2013.08.01324007657
   PubMed Web of Science ®Google Scholar
• MinH, ShaoFU, Xiao-LingF. Screening of panax notoginsenoside water in oil microemulsion formulations and their evaluation in vitro and in vivo. Acta Pharmaceutica Sinica. 2007;42(7):780–786.17882965
   PubMedGoogle Scholar
• OkonogiS, ChaiyanaW. Enhancement of anti-cholinesterase activity of Zingiber cassumunar essential oil using a microemulsion technique. Drug Discov Ther. 2012;6(5):249–255.23229145
   PubMedGoogle Scholar
• ZhangDK, FuMC, LinJZ, et al. Study on theory and application value of ‘unification of medicines and excipients’ in Chinese materia medica preparations. Chin Traditional Herbal Drugs. 2017;10:1921–1929.
   Google Scholar
• QuD, HeJ, LiuC, et al. Triterpene-loaded microemulsion using Coixlacyma-jobi seed extract as oil phase for enhanced antitumor efficacy: preparation and in vivo evaluation. Int J Nanomed. 2014;9(1):109–119.
   PubMedGoogle Scholar
• QuD, SunW, LiuM, et al. Bitargeted microemulsions based on coix seed ingredients for enhanced hepatic tumor delivery and synergistic therapy. Int J Pharm. 2016;503(1–2):90–101. doi:10.1016/j.ijpharm.2016.03.00126947738
   PubMed Web of Science ®Google Scholar
• LuY, LiCS, DongQ. Chinese herb related molecules of cancer-cell-apoptosis: a minireview of progress between Kanglaite injection and related genes. J Exp Clin Cancer Res. 2008;27(1):31. doi:10.1186/1756-9966-27-3118718024
   PubMed Web of Science ®Google Scholar
• WangX, MaC, WangX. Clinical observation on effect of Kanglaite, in treating pulmonary carcinoma patients with Lung-Qi deficiency and immunologic inadequacy after pneumonectomy in treating pulmonary carcinoma patients with Lung-Qi deficiency and immunologic inadequacy after pneumonectomy. Chin J Integr Med. 1999;5(2):105–107.
   Google Scholar
• WuY, ZhangJ, HongY, et al. Effects of Kanglaite injection on serum miRNA-21 in patients with advanced lung cancer. Med Sci Monitor Int Med J Exp Clin Res. 2018;24:2901–2906.
   Google Scholar
• QuD, GuoM, QinY, et al. A multicomponent microemulsion using rational combination strategy improves lung cancer treatment through synergistic effects and deep tumor penetration. Drug Deliv. 2017;24(1):1179–1190. doi:10.1080/10717544.2017.136539428841044
   PubMed Web of Science ®Google Scholar
• LinL, QINL, LIU Ronglin, et al. Optimization of aqueous enzymatic extraction of adlay bran oil by response surface methodology. China Oils Fats. 2015;40(4):1–5.
   Google Scholar
• YangL, ShengyaoT, WeiyingG, et al. Determination of entrapment efficiency of oxaliplatin liposomes by sephadex microcolumn combined with HPLC. Chin J Modern Appl Pharm. 2014;31(1):69–77.
   Google Scholar
• SonaliAP, SinghRP, RajeshCV. et al. Transferrin receptor-targeted vitamin E TPGS micelles for brain cancer therapy: preparation, characterization and brain distribution in rats. Drug Deliv. 2016;23:1788–1798. doi:10.3109/10717544.2015.109468126431064
   PubMed Web of Science ®Google Scholar
• ChangyuanW, TingL, ZongpingT. Study of coix seed extract in its effect on inducing proliferation,apoptosis and p53 expression in human hepatocellular carcinoma. J Guangxi Med Univ. 2001;8:793–795.
   Google Scholar
• BruixJ, ShermanM. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–1022. doi:10.1002/hep.2419921374666
   PubMed Web of Science ®Google Scholar
• ZouWP. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nature Rev Cancer. 2005;5(4):263–274. doi:10.1038/nrc158615776005
   PubMed Web of Science ®Google Scholar
• YanC, DingQ, YihuaM, et al. Microemulsion-based synergistic dual-drug codelivery system for enhanced apoptosis of tumor cells. Int J Nanomed. 2015;10:1173–1187. doi:10.2147/IJN.S76742
   PubMed Web of Science ®Google Scholar
• ZhigangC, HaofengLU, JiyeZ, et al. Anti-proliferative effects of combining Sorafenib and sodium cantharidinate in HepG2 liver cancer cells. Chin J Oncol Prev Treat. 2015;7:85–89.
   Google Scholar
• WangY, ZhangH, HaoJ, et al. Lung cancer combination therapy: co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effect. Drug Deliv. 2015;23(4):1398.26079530
   PubMed Web of Science ®Google Scholar
• HeZ, SunJ, LiL. Deep penetration of nanoparticulate drug delivery systems into tumors: challenges and solutions. Curr Med Chem. 2013;20(23):2881–2891. doi:10.2174/0929867311320999000423651305
   PubMed Web of Science ®Google Scholar
• WongC, StylianopoulosT, CuiJ, et al. Multistage nanoparticle delivery system for deep penetration into tumor tissue. Proc Natl Acad Sci U S A. 2011;108(6):2426–2431. doi:10.1073/pnas.101838210821245339
   PubMed Web of Science ®Google Scholar
• ZhangZH, WangXP, AymanWY, et al. Studies on lactoferrin nanoparticles of gambogic acid for oral delivery. Drug Deliv. 2013;20(2):86–93. doi:10.3109/10717544.2013.76678123495734
   PubMed Web of Science ®Google Scholar
• ZhangL, JiangY, ZhengY, et al. Selective killing of Burkitt’s lymphoma cells by mBAFF-targeted delivery of PinX1. Leukemia. 2011;25:331–340. doi:10.1038/leu.2010.26121102426
   PubMed Web of Science ®Google Scholar
• RavarF, SaadatE, GholamiM, et al. Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation. J Control Release. 2016;229:10–22. doi:10.1016/j.jconrel.2016.03.01226968799
   PubMed Web of Science ®Google Scholar
• SzczepanowiczK, BzowskaM, KrukT, KarabaszA, BeretaJ, WarszynskiP. Pegylated polyelectrolyte nanoparticles containing paclitaxel as a promising candidate for drug carriers for passive targeting. Colloid Surface B. 2016;143:463–471. doi:10.1016/j.colsurfb.2016.03.064
   PubMed Web of Science ®Google Scholar
• AlaviM, HamidiM. Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles. Nephron Clin Pract. 2019;34(1):424–436.
   Google Scholar
• HeshuR, AbdullahR, WunHC, et al. Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect. Int J Nanomed. 2013;8:2769–2781. doi:10.2147/IJN.S45313
   PubMed Web of Science ®Google Scholar
• WangM, QinLL, LiK, et al. The improvement of the anticancer effect of a novel compound benzoic acid, 2-hydroxy-,2-D-ribofuranosylhydrazide (BHR) loaded in solid lipid nanoparticles. AAPS PharmSciTech. 2012;13:1348–1354. doi:10.1208/s12249-012-9862-823054988
   PubMed Web of Science ®Google Scholar